Article Text
Abstract
Objectives: Systemic values of the fibrinolytic plasma marker fibrin D-dimer are raised in a variety of acute clinical conditions. D-dimer values can now be rapidly determined and used to aid diagnosis in emergency medicine. However, despite clinical guidelines, inappropriate and unnecessary measurement of D-dimer values is a significant clinical problem. An understanding of the pathophysiological basis and limitations of the value of D-dimer values may help reduce this problem. This review discusses the pathophysiology of the fibrinolytic system. The currently used assays, clinical indications, and limitations of D-dimer measurement are reviewed. Finally, the potential future clinical indications for measurement of D-dimer values in emergency medicine are discussed.
Methods: Literature on D-dimer was identified from Medline, along with cross referencing from the reference lists of major articles on the subject
Results and conclusions: Systemic D-dimer values aids diagnosis, and is potentially a prognostic indicator, in a variety of clinical conditions in emergency medicine. However, it has limited specificity in patients with comorbid conditions. Although, currently, there is no standard D-dimer assay, immunoturbidimetric assays are the most suitable for use in emergency medicine
- D-dimer
- DD, D-dimer
- VTE, venous thromboembolism
- tPA, tissue plasminogen activator
- XL-Fg, crosslinked fibrin
- FDP, fibrin degradation product
- ELISA, enzyme linked immunosorbent assay
- HMW, high molecular weight
- LMW, low molecular weight
- FACT, Fibrin Assay Comparison Trial
- CT, computed tomography
- PE, pulmonary embolism
- DVT, deep vein thrombosis
- PTP, pretest probability
- CHD, coronary heart disease
- ACS, acute coronary syndrome
- MI, myocardial infarction
Statistics from Altmetric.com
- DD, D-dimer
- VTE, venous thromboembolism
- tPA, tissue plasminogen activator
- XL-Fg, crosslinked fibrin
- FDP, fibrin degradation product
- ELISA, enzyme linked immunosorbent assay
- HMW, high molecular weight
- LMW, low molecular weight
- FACT, Fibrin Assay Comparison Trial
- CT, computed tomography
- PE, pulmonary embolism
- DVT, deep vein thrombosis
- PTP, pretest probability
- CHD, coronary heart disease
- ACS, acute coronary syndrome
- MI, myocardial infarction